title: Platelet aggregation abnormalities after cardiopulmonary bypass.
authors.forename: V A
authors.initials: VA
authors.lastname: Ferraris
authors.forename: E
authors.initials: E
authors.lastname: Rodriguez
authors.forename: S P
authors.initials: SP
authors.lastname: Ferraris
authors.forename: M
authors.initials: M
authors.lastname: Huang
authors.forename: A
authors.initials: A
authors.lastname: Gupta
authors.forename: J A
authors.initials: JA
authors.lastname: Bennett
authors.forename: T T
authors.initials: TT
authors.lastname: Andersen
authors.forename: H
authors.initials: H
authors.lastname: Dunn
authors.forename: J W
authors.initials: JW
authors.lastname: Fenton
authors.forename: J B
authors.initials: JB
authors.lastname: Smith
mesh_terms: D002315:Cardiopulmonary Bypass / Q000009:adverse effects*; D006801:Humans; D010446:Peptide Fragments / Q000494:pharmacology; D010974:Platelet Aggregation; D015800:Protozoan Proteins / Q000494:pharmacology; D013917:Thrombin / Q000494:pharmacology
chemical_list: D010446:Peptide Fragments; D015800:Protozoan Proteins; C069428:thrombospondin-related adhesive protein, protozoan; C072032:thrombin receptor peptide (42-55); D013917:Thrombin